Equities

Vaishali Pharma Ltd

VAISHALI:NSI

Vaishali Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)192.91
  • Today's Change-0.09 / -0.05%
  • Shares traded63.08k
  • 1 Year change+56.84%
  • Beta0.6936
Data delayed at least 15 minutes, as of Sep 20 2024 11:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments135124130
Total Receivables, Net501536585
Total Inventory104316.29
Prepaid expenses0.43----
Other current assets, total5.513643
Total current assets745727764
Property, plant & equipment, net15189.04
Goodwill, net------
Intangibles, net8.028.567.69
Long term investments182726
Note receivable - long term7.17----
Other long term assets4.907.177.16
Total assets800789816
LIABILITIES
Accounts payable194180284
Accrued expenses3.15----
Notes payable/short-term debt7673167
Current portion long-term debt/capital leases20139.74
Other current liabilities, total375459
Total current liabilities331321519
Total long term debt386131
Total debt135147208
Deferred income tax------
Minority interest------
Other liabilities, total2.001.891.89
Total liabilities371384553
SHAREHOLDERS EQUITY
Common stock107105105
Additional paid-in capital170----
Retained earnings (accumulated deficit)149----
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.82300158
Total equity428405264
Total liabilities & shareholders' equity800789816
Total common shares outstanding111111
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.